Valuation: Vext Science, Inc.

Market Cap 43.96M 39.13M 36.28M 32.86M 61.81M 4.17B 62.72M 434M 171M 2.18B 165M 161M 6.96B P/E 2026 *
-
P/E 2027 * 17.9x
Enterprise Value 63.47M 56.5M 52.38M 47.45M 89.26M 6.02B 90.56M 627M 246M 3.15B 238M 233M 10.04B EV / Sales 2026 *
1.18x
EV / Sales 2027 * 0.8x
Free-Float
40.74%
Yield 2026 *
-
Yield 2027 * -
1 day+2.00%
1 week-1.92%
Current month+8.51%
6 months-5.56%
1 week 0.23
Extreme 0.23
0.26
1 month 0.21
Extreme 0.21
0.26
Current year 0.21
Extreme 0.21
0.4
1 year 0.19
Extreme 0.19
0.4
3 years 0.1
Extreme 0.1
0.42
5 years 0.1
Extreme 0.1
0.92
10 years 0.1
Extreme 0.1
2.1
Manager TitleAgeSince
Chief Executive Officer - 2020-02-17
Director of Finance/CFO - 2023-08-24
Investor Relations Contact - -
Director TitleAgeSince
Chairman 45 2015-12-10
Director/Board Member - 2020-02-13
Chairman 69 2024-08-19
Date Insider Type Main position Quantity % Market Cap. Importance
1/5/26 Sell

Director

1,334,000 0.8075%
1/5/26 Sell

Founder

20,340 2.9973%
1/5/26 Other

Director

0 0%
Change 5-day change 1-year change 3-year change Capi.($)
+2.00%-1.92%-16.39%-12.07% 43.96M
+2.23%+7.99%+14.82%+34.19% 119B
+2.39%+1.56%+9.29%+90.84% 98.48B
+1.63%+2.05%+123.41%+879.77% 57.57B
-0.38%+4.43%-5.74%+80.34% 28.37B
+0.94%+1.93%+25.12%+93.05% 25.93B
+1.35%+2.41%+13.01%+62.03% 25.86B
+2.23%+1.32%+36.16%+382.58% 21.45B
-0.41%-3.19%-21.76%-5.09% 20.45B
+1.71%-3.63%+8.09%+90.87% 18.69B
Average +1.30%-0.06%+18.60%+169.65% 41.54B
Weighted average by Cap. +1.62%+1.51%+26.68%+191.98%

Financials

2026 *2027 *
Net sales 53.8M 47.89M 44.4M 40.22M 75.65M 5.1B 76.76M 532M 209M 2.67B 202M 198M 8.51B 65.6M 58.39M 54.14M 49.04M 92.24M 6.22B 93.59M 648M 255M 3.25B 246M 241M 10.38B
Net income -900K -801K -743K -673K -1.27M -85.29M -1.28M -8.89M -3.49M -44.63M -3.38M -3.31M -142M 3.22M 2.87M 2.66M 2.41M 4.53M 305M 4.6M 31.82M 12.5M 160M 12.08M 11.83M 510M
Net Debt 19.52M 17.37M 16.11M 14.59M 27.44M 1.85B 27.85M 193M 75.78M 968M 73.2M 71.68M 3.09B 8.69M 7.73M 7.17M 6.5M 12.22M 823M 12.4M 85.85M 33.74M 431M 32.59M 31.91M 1.38B
Projected Income Statement - Annual - Vext Science, Inc.
Logo Vext Science, Inc.
Vext Science, Inc. is a cannabis operator with vertical operations in Arizona and Ohio. The Company's expertise spans from cultivation through to retail operations in its key markets. The Company owns and operates cultivation facilities, fully built-out manufacturing facilities as well as dispensaries in both Arizona and Ohio. The Company produces a range of branded offerings, including its Vapen, Revibe, Herbal Wellness Center, and Appalachian Pharm lines. The Company manufactures Vapen, one of the THC concentrates, edibles, and distillate cartridge brands in Arizona. It produces CBD products under the Vapen CBD and Hempy Endings brands, manufactured at its Vapen Kentucky facility. Through strategic licensing agreements, it manufactures the Microbar brand in Arizona. The Company extends its services to the cannabis industry by offering management, advisory, cultivation, non-cannabis products, and dispensary services through operating agreements and direct sales to various entities.
Employees
-
Date Price Change Volume
26-10-20 $0.2550 +2.00% 17,000
26-10-19 $0.2500 +4.17% 5,000
26-10-16 $0.2400 -2.04% 10,500
26-10-15 $0.2450 +2.08% 7,500
26-10-14 $0.2400 +4.35% 86,500
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
MarketScreener Ratings - Vext Science, Inc.
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
0.2550CAD
Average target price
0.9500CAD
Spread / Average Target
+272.55%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - Vext Science, Inc.
  1. Stock Market
  2. Stocks
  3. VEXT Stock